Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fdg-PET”

884 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 884 results

Testing effectiveness (Phase 2)Study completedNCT00633022
What this trial is testing

Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

Who this might be right for
Atherosclerosis
GlaxoSmithKline 99
Not applicableStudy completedNCT01916005
What this trial is testing

Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis

Who this might be right for
Prosthetic Valve Endocarditis (PVE)
Assistance Publique Hopitaux De Marseille 174
Testing effectiveness (Phase 2)UnknownNCT05879471
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 39
Not applicableNot Yet RecruitingNCT07130344
What this trial is testing

PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer

Who this might be right for
Metastatic Breast CancerHER 2 Low-expressing Breast Cancer
Centre Paul Strauss 262
Large-scale testing (Phase 3)Study completedNCT03891914
What this trial is testing

Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma

Who this might be right for
Myeloma Multiple
University Hospital, Bordeaux 20
Not applicableNot Yet RecruitingNCT06494800
What this trial is testing

Added Value of PET/CT in Lung Cancer

Who this might be right for
Lung Cancer
Sohag University 30
Large-scale testing (Phase 3)UnknownNCT05428475
What this trial is testing

Implementation and Evaluation of Improved Access to Medical Imaging for Geriatric Patients of The Royal Ottawa Hospital

Who this might be right for
DementiaCognitive ImpairmentDementia With Lewy Bodies
Tim Lau 15
Not applicableStudy completedNCT02300402
What this trial is testing

Detection and Characterization of Residual Masses in Lymphomas

Who this might be right for
Hodgkin LymphomaB-Cell Lymphoma
The Lymphoma Academic Research Organisation 120
Not applicableEnrolling By InvitationNCT05108857
What this trial is testing

PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9

Who this might be right for
Systemic Sclerosis
Turku University Hospital 10
Not applicableStudy completedNCT01621529
What this trial is testing

Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer

Who this might be right for
Infiltrating Ductal Carcinoma
Centre Henri Becquerel 30
Not applicableUnknownNCT01322477
What this trial is testing

Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency

Who this might be right for
Hepatocellular Carcinoma
Hadassah Medical Organization 25
Not applicableWithdrawnNCT04514328
What this trial is testing

Highlighting the Benefits of Therapeutic Gardens in Alzheimer's Disease by 18F-FDG Cerebral PET /CT

Who this might be right for
Alzheimer Disease
Central Hospital, Nancy, France
Not applicableStudy completedNCT02309567
What this trial is testing

Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?

Who this might be right for
Lung NeoplasmsGene, p53
Cumhuriyet University 146
Testing effectiveness (Phase 2)UnknownNCT04502303
What this trial is testing

18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease

Who this might be right for
Crohn Disease
Peking Union Medical College Hospital 30
Large-scale testing (Phase 3)Study completedNCT01478542
What this trial is testing

OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

Who this might be right for
CD20+ Aggressive B-Cell Lymphoma
Universität des Saarlandes 1,152
Not applicableUnknownNCT05577299
What this trial is testing

Factors Affecting BAT Activation in PET/CT

Who this might be right for
Factors Affecting BAT Activation in PET/CT
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT00086333
What this trial is testing

FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma

Who this might be right for
Non-Small Cell Lung Carcinoma
Seagen Inc. 30
Not applicableActive Not RecruitingNCT02386709
What this trial is testing

Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer

Who this might be right for
FDG PET
Centre Georges Francois Leclerc 275
Testing effectiveness (Phase 2)Study completedNCT03602911
What this trial is testing

A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West Virginia University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05710328
What this trial is testing

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2-Positive Breast Carcinoma+1 more
ECOG-ACRIN Cancer Research Group 235
Load More Results